Efficacy and Safety of Fluvastatin in Children With Heterozygous Familial Hypercholesterolemia

Efficacy and Safety of Fluvastatin in Children With Heterozygous Familial Hypercholesterolemia

The purpose of the study is to assess the safety and efficacy of fluvastatin in children diagnosed with heterozygous familial hypercholesterolemia

Inclusion Criteria:

• 10-16 years old Heterozygous familial hypercholesterolemia

Exclusion Criteria:

• Homozygous familial hypercholesterolemia Pregnant or lactating females Major surgery during the six month prior study

Other protocol defined inclusion and exclusion criteria may apply